This article was originally published on ETFTrends.com.
ETF investors interested in the growth opportunities found in the biotechnology segment can look to initiatives in the health care segment, such as the developments in CRISPR genome-editing. On the recent webcast (available On Demand for CE Credit), As Genome-Editing Evolves, So Do The Investment Opportunities, Brett Winton, Director of Research at ARK Invest, highlighted […]
Continue Reading Below
